Ariane J. Sousa-Batista
Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles
Sousa-Batista, Ariane J.; Arruda-Costa, Natalia; Escrivani, Douglas O.; Reynaud, Franceline; Steel, Patrick G.; Rossi-Bergmann, Bartira
Authors
Natalia Arruda-Costa
Douglas O. Escrivani
Franceline Reynaud
Professor Patrick Steel p.g.steel@durham.ac.uk
Professor
Bartira Rossi-Bergmann
Abstract
Cutaneous leishmaniasis (CL) is a major health problem in many countries and its current treatment involves multiple parenteral injections with toxic drugs and requires intensive health services. Previously, the efficacy of a single subcutaneous injection with a slow-release formulation consisting of poly(lactide-co-glycolide) (PLGA) microparticles loaded with an antileishmanial 3-nitro-2-hydroxy-4,6-dimethoxychalcone (CH8) was demonstrated in mice model. In the search for more easily synthesized active chalcone derivatives, and improved microparticle loading, CH8 analogues were synthesized and tested for antileishmanial activity in vitro and in vivo. The 3-nitro-2′,4′,6′-trimethoxychalcone (NAT22) analogue was chosen for its higher selectivity against intracellular amastigotes (selectivity index = 1489, as compared with 317 for CH8) and more efficient synthesis (89% yield, as compared with 18% for CH8). NAT22 was loaded into PLGA / polyvinylpyrrolidone (PVP) polymeric blend microspheres (NAT22-PLGAk) with average diameter of 1.9 μm. Although NAT22-PLGAk showed similar activity to free NAT22 in killing intracellular parasites in vitro (IC50 ~ 0.2 μm), in vivo studies in Leishmania amazonensis – infected mice demonstrated the significant superior efficacy of NAT22-PLGAk to reduce the parasite load. A single intralesional injection with NAT22-PLGAk was more effective than eight injections with free NAT22. Together, these results show that NAT22-PLGAk is a promising alternative for single-dose localized treatment of CL.
Citation
Sousa-Batista, A. J., Arruda-Costa, N., Escrivani, D. O., Reynaud, F., Steel, P. G., & Rossi-Bergmann, B. (2020). Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles. Parasitology, 147(9), 1032-1037. https://doi.org/10.1017/s0031182020000712
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 25, 2020 |
Online Publication Date | May 4, 2020 |
Publication Date | 2020-08 |
Deposit Date | Jun 4, 2020 |
Publicly Available Date | Nov 4, 2021 |
Journal | Parasitology |
Print ISSN | 0031-1820 |
Electronic ISSN | 1469-8161 |
Publisher | Cambridge University Press |
Peer Reviewed | Peer Reviewed |
Volume | 147 |
Issue | 9 |
Pages | 1032-1037 |
DOI | https://doi.org/10.1017/s0031182020000712 |
Public URL | https://durham-repository.worktribe.com/output/1263247 |
Files
Accepted Journal Article
(858 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
This article has been published in a revised form in Parasitology http://doi.org/10.1017/S0031182020000712. This version is published under a Creative Commons CC-BY-NC-ND. No commercial re-distribution or re-use allowed. Derivative works cannot be distributed. © The Author(s) 2020.
You might also like
TREATMENT OF LEISHMANIASIS
(2024)
Patent
Synthesis and vectorial functionalisation of pyrazolo[3,4- c ]pyridines
(2023)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search